Good ML/bioinformatics target.
More about Axiom Therapeutics
Axiom Therapeutics is a techbio company based in London, UK, founded in 2024. The company focuses on drug discovery, utilizing an advanced computational artificial intelligence platform that employs machine learning-accelerated physics simulations. This innovative approach aims to develop precise and potent therapies for diseases that are traditionally difficult to treat. The company operates as a pre-seed stage establishment with a small team of 1-10 employees. Co-founders Ryan Geiser and Chris Haggard, both PhD graduates from the University of Cambridge, bring together expertise in both wet-lab and dry-lab environments. Axiom Therapeutics is committed to pioneering AI-powered covalent drug discovery, emphasizing the design of next-generation therapeutics.
Live roles
Alert me when Axiom Therapeutics posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- Kymab / Sanofi Cambridge 47 live
- Cambridge Consultants 40 live
Capgemini-owned deep-tech consultancy; Science Park HQ. Hardware, AI, medtech, wireless.
- PA Consulting (Global Innovation & Tech Centre) 17 live
Melbourn technology campus.
- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- AVEVA 13 live
Industrial software giant (Schneider Electric); CONNECT cloud platform, PI System, asset performance management.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.